Regadenoson 00641-6253
Product NDC
00641-6253- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 3, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA215827
Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Regadenoson Anhydrous | .08 mg/mL |
Drug Class
Pharmacologic Cardiac Stress Test Agent [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]
Packaging Options(1)
1 SYRINGE, PLASTIC in 1 CARTON (0641-6253-01) / 5 mL in 1 SYRINGE, PLASTIC